期刊文献+

Fas/FasL及p53在视网膜母细胞瘤中的表达及意义 被引量:1

The expression of Fas/FasL and p53 in retinoblastoma
暂未订购
导出
摘要 目的 探讨 Fas、Fas L及 p5 3在视网膜母细胞瘤中的表达及意义。方法 用 S- P方法检测 45例视网膜母细胞瘤及 12例正常视网膜组织中 Fas、Fas L及 p5 3蛋白的表达。结果  Fas在视网膜母细胞瘤组织及正常视网膜组织中均呈低表达 ,差异无显著性 (P>0 .0 5 ) ;Fas L在视网膜母细胞瘤及正常视网膜组织中均呈高表达 ,差异无显著性 (P>0 .0 5 ) ;p5 3在视网膜母细胞瘤中的表达较强 ,而在正常视网膜组织中的表达极弱 ,差异有极显著性 (P<0 .0 0 2 )。结论  Fas L在视网膜母细胞瘤及正常视网膜中均呈现高表达 ,与肿瘤细胞的免疫逃逸机制有关 ;突变型 p5 3在视网膜母细胞瘤中的表达明显高于正常视网膜组织 ,可能抑制肿瘤凋亡的发生 ,促进肿瘤的生长。 Objective To investigate the siginificance of Fas/FasL and p53 expression in retinoblastoma.Methods FasL,Fas and bcl 2 were detected immunohistochemically in 45 cases of retinoblastoma and 12 cases of normal retina.Results The expression of Fas in retinoblastoma and normal retina were very low with no difference( P >0.05).The expression of FasL in retinoblastoma and normal retina were high,but with no significantly difference( P >0.05).p53 was highly expressed in retinoblastoma and low expressed in normal retina,with significant difference( P <0.0002).Conclusion High expression of FasL and low expression of Fas in retinoblastoma and normal retina suggested that they might be associated with immune escape.The high expression of p53 in retinoblastoma was closely associated with the tumor development.\;
出处 《实用肿瘤杂志》 CAS 北大核心 2001年第2期97-99,共3页 Journal of Practical Oncology
关键词 视网膜母细胞瘤 细胞凋亡 FAS/FASL 逃逸反应 基因表达 retinoblastoma FasL Fas p53 escape reaction gene
  • 相关文献

参考文献9

  • 1[1]Kawahara A, Kobayashi T, Nagata S. Inhibition of Fas-induced apoptosis by bcl-2[J]. Oncogene, 1998,17 (20): 2549- 2554.
  • 2[2]Geradts J,Kratzke RA,Spliiare EA,et al. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 product p16 in archival human solid tumors:correlation with retinoblastoma protein expression [J]. Cancer Res,1995,55 (41): 6006- 6011.
  • 3[3]Mitsiades N,Poulaki V,Kotoula V,et al. Fas/fas ligand up-regulation and bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroditis [J]. J Clin Endocrinol Metab, 1998,83 (6): 2199 -2203.
  • 4[4]Kondo E,Yoshino T,Yamadori I,et al. Expression of bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas[J]. Am J Pathol, 1994,145 (2): 330- 337.
  • 5[5]Ungefroren H,Voss M,Jansen M,et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis[J]. Cancer Res, 1998,58(8): 1741- 1749.
  • 6[6]Hamazki K,Gochi A,Matsubarn N,et al. Expression of Fas antigen and bcl-2 protein in hepatocellular carcinoma [J]. Acta Med Okayama, 1995,49 (4): 227 -230.
  • 7[7]Sasaki Y, Ahmed H, Takeuchi T, et al. Immunohistochemical study of Fas,Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer[J]. Br J Urol, 1998,81 (6): 852- 855.
  • 8[8]Catherine G,Yasuo T,Christoph B,et al. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer [J]. Cancer Res, 1998,58 (15 ): 2057 - 2062.
  • 9[9]Thomas SG,Thomas B,Sharon M,et al. Fas ligand-induced apoptosis as a mechanism of immune privilege [J]. Science, 1995,270(17): 1189- 1192.

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部